New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential (Q33209665)

23 July 2017

1 reference

title

New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential (English)

1 reference

attention deficit hyperactivity disorder

23 July 2017

1 reference

1 reference

Daniel F Connor

1

1 reference

PubMed ID

15584770

23 July 2017

Ronald J Steingard

series ordinal

2

1 reference

23 July 2017

1 January 2004

1 reference

23 July 2017

1 reference

23 July 2017

18

1 reference

23 July 2017

14

1 reference

23 July 2017

1011-1030

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200418140-00005

23 July 2017

0 references

cites work

Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain

1 reference

12 December 2020

The prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents.

1 reference

12 December 2020

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

1 reference

12 December 2020

Enantioselective behavioral effects of threo-methylphenidate in rats

1 reference

12 December 2020

Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15 year olds

1 reference

12 December 2020

Medication treatment strategies in the MTA Study: relevance to clinicians and researchers.

1 reference

12 December 2020

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Separation of ritalin racemate and its by-product racemates by capillary electrophoresis

1 reference

12 December 2020

Pharmacotherapy of attention deficit hyperactivity disorder

1 reference

12 December 2020

Methylphenidate (OROS formulation).

1 reference

12 December 2020

A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Catecholamines in attention-deficit hyperactivity disorder: current perspectives

1 reference

12 December 2020

The diagnosis and prevalence of hyperactivity in Chinese schoolboys

1 reference

12 December 2020

Young adult follow-up of hyperactive children: self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD.

1 reference

12 December 2020

Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: findings from a high-risk sample of siblings

1 reference

12 December 2020

Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children.

1 reference

12 December 2020

Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study

1 reference

12 December 2020

Chiral drugs: comparison of the pharmacokinetics of [11C]d-threo and L-threo-methylphenidate in the human and baboon brain

1 reference

12 December 2020

Attention-deficit/hyperactivity disorder: a life-span perspective.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a reanalysis using drug-placebo and drug-drug response curve methodology

1 reference

12 December 2020

Epidemiology and course of psychiatric disorders in school-age children--results of a longitudinal study

1 reference

12 December 2020

Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

1 reference

12 December 2020

Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings

1 reference

12 December 2020

Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis.

1 reference

12 December 2020

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder

1 reference

12 December 2020

The dopamine theory of attention deficit hyperactivity disorder (ADHD).

1 reference

12 December 2020

Sustained release methylphenidate: pharmacokinetic studies in ADDH males

1 reference

12 December 2020

The biochemical pharmacology of abused drugs. I. Amphetamines, cocaine, and LSD.

1 reference

12 December 2020

DSM-III disorders in a large sample of adolescents

1 reference

12 December 2020

Attention Deficit Hyperactivity Disorder (ADHD) is Associated with Early Onset Substance Use Disorders

1 reference

12 December 2020

Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?

1 reference

12 December 2020

Behavioral predictors of injury in school-age children

1 reference

12 December 2020

Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Attention-deficit hyperactivity disorder

1 reference

12 December 2020

DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population

1 reference

12 December 2020

Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration.

1 reference

12 December 2020

Hyperkinetic impulse disorder in children's behavior problems.

1 reference

12 December 2020

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

1 reference

12 December 2020

Methylphenidate bioavailability in adults when an extended-release multiparticulate formulation is administered sprinkled on food or as an intact capsule

1 reference

12 December 2020

ADHD is associated with early initiation of cigarette smoking in children and adolescents

1 reference

12 December 2020

The neurobiology of attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

ADHD in a school sample of Brazilian adolescents: a study of prevalence, comorbid conditions, and impairments

1 reference

12 December 2020

ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study

1 reference

12 December 2020

Dexmethylphenidate (Focalin) for ADHD

1 reference

12 December 2020

ADHD in Brazil: the DSM-IV criteria in a culturally different population.

1 reference

12 December 2020

The stimulants revisited.

1 reference

12 December 2020

Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder

1 reference

12 December 2020

Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study

1 reference

12 December 2020

Effect of food on early drug exposure from extended-release stimulants: results from the Concerta, Adderall XR Food Evaluation (CAFE) Study

1 reference

12 December 2020

Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder

1 reference

12 December 2020

Pemoline hepatotoxicity and postmarketing surveillance

1 reference

12 December 2020

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

1 reference

12 December 2020

SLI381: a long-acting psychostimulant preparation for the treatment of attention-deficit hyperactivity disorder

1 reference

12 December 2020

International consensus statement on ADHD. January 2002.

1 reference

12 December 2020

Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD.

1 reference

12 December 2020

Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample

1 reference

12 December 2020

Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry

1 reference

12 December 2020

Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures.

1 reference

12 December 2020

Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-[3H]norepinephrine and [3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus

1 reference

12 December 2020

ADHD: current concepts on etiology, pathophysiology, and neurobiology

1 reference

12 December 2020

Comparison of attention-deficit/hyperactivity disorder symptom subtypes in Ukrainian schoolchildren

1 reference

12 December 2020

1 reference

12 December 2020

Mirror, mirror on the wall, which enantiomer is fairest of them all?

1 reference

12 December 2020

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

1 reference

12 December 2020

Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD.

1 reference

12 December 2020

Further evidence of an association between attention-deficit/hyperactivity disorder and cigarette smoking. Findings from a high-risk sample of siblings

1 reference

12 December 2020

Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico. The use of combined measures

1 reference

12 December 2020

Attention deficit disorder with hyperactivity among paediatric outpatients

1 reference

12 December 2020

Neurobiology of attention-deficit hyperactivity disorder.

1 reference

12 December 2020

Impact of adversity on functioning and comorbidity in children with attention-deficit hyperactivity disorder.

1 reference

12 December 2020

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

1 reference

12 December 2020

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

1 reference

12 December 2020

10.2165/00023210-200418140-00005

Identifiers

DOI

1 reference

PubMed ID

15584770

Dimensions Publication ID

23 July 2017

0 references

1 reference

PubMed ID

15584770